Cargando…
Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disorders
Pharmacogenomics is the study of the effects of genetic polymorphisms on medication pharmacokinetics and pharmacodynamics. It offers advantages in predicting drug efficacy and/or toxicity and has already changed clinical practice in many fields of medicine. Tardive dyskinesia (TD) is a movement diso...
Autores principales: | Chang, Florence CF, Fung, Victor SC |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207069/ https://www.ncbi.nlm.nih.gov/pubmed/25378945 http://dx.doi.org/10.2147/PGPM.S52806 |
Ejemplares similares
-
Tardive Dyskinesia: Treatment with Aripiprazole
por: Kang, Na-Ri, et al.
Publicado: (2011) -
Tardive Dyskinesia Associated with Bupropion
por: Tuman, Taha Can, et al.
Publicado: (2017) -
METOCLOPRAMIDE IN TARDIVE DYSKINESIA
por: Hemanani, T.J., et al.
Publicado: (1983) -
Treatment of neurolept-induced tardive dyskinesia
por: Jankelowitz, Stacey K
Publicado: (2013) -
Recent Advances in the Pharmacology of Tardive Dyskinesia
por: Caroff, Stanley N.
Publicado: (2020)